Ovarian cysts in women receiving tamoxifen for breast cancer

British Journal of Cancer

Volumn 79, Issue 11-12, 1999, Pages 1761-1764

  Mourits, M J E ^a   De Vries, E G E ^a   Willemse, P H B ^a   Ten Hoor, K A ^a   Hoollema, H ^a   Sluiter, W J ^a   De Bruijn, H W A ^a   Van Der Zee, A G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Breast cancer; Chemotherapy; FSH; Oestradiol; Ovarian cysts; Tamoxifen

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; ESTRADIOL; FLUOROURACIL; FOLLITROPIN; TAMOXIFEN;

ADULT; AGE; AGED; AMENORRHEA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTIPLE REGRESSION; OVARY CYST; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY;

EID: 0033040181     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690280     Document Type: Article

References (27)

1. Andersson M, Storm HH and Mouridson HT (1991) Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83: 1013-1017
2. Barbieri RL, Ferracci AL, Droesch JN and Rochelson BL (1993) Ovarian torsion in a premenopausal woman treated for breast cancer. Fertil Steril 59: 459-460
3. Bines J, Oleske DM and Cobleigh MA (1996) Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14: 1718-1729
4. Boccardo F, Rubagotti A, Amoroso D, Sismondi P, Genta F, Nenci I, and other participants in the GROCTA (1992) Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st Grocta (Breast Cancer Adjuvant Chemo-hormone Therapy Cooperative Group) Trial. Eur J Cancer 28: 673-680.
5. Cohen I, Beyth Y, Tepper R, Shapira J, Zalel Y, Figer A, Cordoba M, Yigael D and Altaras MM (1996) Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Oncol 60: 54-58
6. Cohen I, Rosen DJD, Altaras MM, Beyth Y, Shapira J and Yigael D (1994) Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian over-stimulation, cystic formations and fibroid overgrowth. Br J Cancer 63: 620-621
7. Early Breast Cancer Trialists' Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 339: 1-15
8. Fisher B and Redmond C (1991) New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent, J Natl Cancer Inst 83: 1278-1280
9. Fornander T, Cedermark B, Mattson A, Skoog L, Theve T, Askergren J, Rutquist LE, Glas U, Silfversward C, Somell A, Wilkins N and Hjalmar ML (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 117-120
10. Gerhard I and Runnebaum B (1979) Comparison between tamoxifen and clomiphene therapy in women with anovulation. Archives of Gynaecology 227: 279-288
11. Granberg S, Wikland M and Jansson I (1989) Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. Gynecol Oncol 35: 139-144
12. Jolles CJ, Smotkin D, Ford KL and Jones KP (1990) Cystic ovarian necrosis complicating tamoxifen therapy for breast cancer in a premenopausal woman: a case report. J Reprod Med 35: 299-300
13. Jurjens H, Pratt JJ and Woldring MG (1975) Radioimmunoassay of plasma estradiol without extraction and chromatography. J Clin Endocrinol Metab 40: 35-41
14. Narod SA, Risch H, Moslehi R, Dorum A, Neuhausen S, Olsson H, Provencher D, Radice P, Evans G, Bishop S, Brunet J-S and Ponder BAJ (1998) Oral contraceptives and the risk of hereditary ovarian cancer. N Engl J Med 339: 424-428
15. Powles TJ, Jones AL, Ashley SE, O'Brien MER, Tidy VA, Treleaven J, Cosgrove D, Nash AG, Sacks N, Baum M, McKinna JA and Davey JB (1994) The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat 31: 73-82
16. Re A, Wierdis T, Tassarolo M, Leo L, Bellino R, Lauricella A and Lanza A (1994) Two cases of ovarian cysts in postmenopausal patients under antiestrogen treatment. Clin Exp Obstet Gynecol 4: 221-224
17. Rossing MA. Daling JR, Weiss NS, Moore DE and Self SG (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331: 771-776
18. Santen RJ, Manni A, Harvey H and Redmond C (1990) Endocrine treatment of breast cancer in women. Endocr Rev 11: 221-265
19. Seoud MAF, Johnson J and Weed JC (1993) Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 82: 165-169
20. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, et al (1995) A collaborative survey of 80 mutations in thc BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA 273: 535-541
21. Shulman A, Cohen I, Altaras MM, Maymon R, Ben-Nun I, Tepper R, and Beyth Y (1994) Ovarian cyst formation in two premenopausal patients treated with tamoxifen for breast cancer. Hum Reprod 9: 1427-1429
22. Shushan A, Peretz T, Uziely B, Lewin A and Mor-Yosef S (1996) Ovarian cysts in premenopausal and tamoxifen-treated women with breast cancer. Am J Obstet Gynecol 174: 141-144
23. Speroff L, Glass RH and Kase NG (1994) Regulation of the menstrual cycle. In: Clinical gynecologic endocrinology and infertility. Mitchell (ed), 5th edn, pp 183-230. Williams and Wilkins: Baltimore
24. Spicer DV, Pike MC and Henderson BE (1991) Ovarian cancer and long-term tamoxifen in premenopausal women (letter). Lancet 337: 1414.
25. Terada S, Uchide K. Suzuki N and Akasofu K (1993) A follicular cyst during tamoxifen therapy in a premenopausal breast cancer woman. Gynecol Obstet Invest 35: 62-64
26. Van Leeuwen FE, Benraadt J, Coebergh JWW, Kiemeney LALM, Gimbrere CHF Otter R, Schouten LJ, Darnhuis RA, Bontenbal M, Diepenhorst FW, Van den Bell-Dusebout AW and Van Tinteren H (1994) Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343: 448-452
27. Whittemore AS, Harris R and Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. Am J Epidemiol 132: 1184-1203